The goal of this study is to compare pain levels in individuals with Sickle Cell Disease while following the Mediterranean Diet to pain levels while following their usual diet.
This is an exploratory, randomized, crossover-controlled feeding study of a 4-week Mediterranean Diet or usual diet control among 24 adults with sickle cell disease and chronic pain (30 will be recruited, with an estimated 24 participants completing the study).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
30
Mediterranean Diet foods will be provided for 4 weeks.
Participants will consume their typical at home-diet.
University of Illinois Chicago
Chicago, Illinois, United States
RECRUITINGSerum and Fecal Short Chain Fatty Acids
Mass spectrometry methods for butyrate, propionate, acetate
Time frame: Baseline and day 27 or 28 of each diet
Serum and Fecal Bile Acid Metabolites
Mass spectrometry methods for primary and secondary bile acid derivatives
Time frame: Baseline and day 27 or 28 of each diet
Gut Microbiota Composition
16S rRNA amplicon
Time frame: Baseline and day 27 or 28 of each diet
Chronic Pain
Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity Survey will be used to measure the experience of chronic pain on a 1-10 scale. The higher the number, the greater the chronic pain experience.
Time frame: Baseline and day 27 or 28 of each diet
Diet adherence
Checklist- participants will keep a checklist of foods consumed during the Mediterranean diet intervention period.
Time frame: Daily up to 4 weeks during the Mediterranean diet intervention
Diet adherence
Photos of uneaten foods will be texted to researchers to see which foods were not consumed.
Time frame: Daily up to 4 weeks during the Mediterranean diet intervention
Diet adherence
Skin carotenoid concentration
Time frame: Baseline and day 27 or 28 of each diet
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.